Complex regional pain syndrome, or CRPS, is an umbrella term that describes long-term pain and inflammation occurring after ...

BRC-002 is an oral botanically-derived cannabinoid agent expected to reduce the pain and comorbidities associated with CRPS. The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol ...

The primary endpoint is the change from baseline in pain intensity and unpleasantness ratings using an 11-point visual analog scale in response to heat and ongoing CRPS pain. “The Orphan Drug ...